SWEETGREEN INC - CLASS A (SG)

US87043Q1085 - Common Stock

33.14  +1.05 (+3.27%)

After market: 33.06 -0.08 (-0.24%)

Fundamental Rating

4

SG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. SG has a great financial health rating, but its profitability evaluates not so good. SG is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

SG had negative earnings in the past year.
SG had a positive operating cash flow in the past year.
In the past 5 years SG always reported negative net income.
SG had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -10.34%, SG is not doing good in the industry: 88.46% of the companies in the same industry are doing better.
With a Return On Equity value of -19.16%, SG is not doing good in the industry: 62.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.34%
ROE -19.16%
ROIC N/A
ROA(3y)-18.09%
ROA(5y)-25%
ROE(3y)-27.38%
ROE(5y)-34.75%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SG has a Gross Margin of 28.17%. This is amonst the worse of the industry: SG underperforms 80.00% of its industry peers.
In the last couple of years the Gross Margin of SG has declined.
The Profit Margin and Operating Margin are not available for SG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.07%
GM growth 5Y-3.64%

More info and screens

9

2. Health

2.1 Basic Checks

SG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SG has more shares outstanding
Compared to 5 years ago, SG has less shares outstanding
There is no outstanding debt for SG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SG has an Altman-Z score of 5.10. This indicates that SG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.10, SG belongs to the top of the industry, outperforming 87.69% of the companies in the same industry.
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.1
ROIC/WACCN/A
WACC9.21%

2.3 Liquidity

A Current Ratio of 2.59 indicates that SG has no problem at all paying its short term obligations.
The Current ratio of SG (2.59) is better than 93.08% of its industry peers.
A Quick Ratio of 2.57 indicates that SG has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.57, SG belongs to the top of the industry, outperforming 93.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.57

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.86% over the past year.
The Revenue has grown by 21.72% in the past year. This is a very strong growth!
The Revenue has been growing by 21.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)21.72%
Revenue growth 3Y38.34%
Revenue growth 5Y21.51%
Sales Q2Q%13.04%

3.2 Future

SG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.98% yearly.
Based on estimates for the next years, SG will show a quite strong growth in Revenue. The Revenue will grow by 18.61% on average per year.
EPS Next Y17.79%
EPS Next 2Y23.55%
EPS Next 3Y18.73%
EPS Next 5Y16.98%
Revenue Next Year16.55%
Revenue Next 2Y16.63%
Revenue Next 3Y17.69%
Revenue Next 5Y18.61%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SG. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SG's earnings are expected to grow with 18.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.55%
EPS Next 3Y18.73%

More info and screens

0

5. Dividend

5.1 Amount

SG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SWEETGREEN INC - CLASS A

NYSE:SG (1/3/2025, 8:04:01 PM)

After market: 33.06 -0.08 (-0.24%)

33.14

+1.05 (+3.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners93.73%
Inst Owner Change6.83%
Ins Owners1.93%
Ins Owner Change-1%
Market Cap3.83B
Analysts80
Price Target42.43 (28.03%)
Short Float %13.28%
Short Ratio4.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.57%
Min EPS beat(2)-32.59%
Max EPS beat(2)-26.56%
EPS beat(4)1
Avg EPS beat(4)-20.66%
Min EPS beat(4)-32.59%
Max EPS beat(4)0.16%
EPS beat(8)2
Avg EPS beat(8)-14.83%
EPS beat(12)4
Avg EPS beat(12)-14.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.38%
Min Revenue beat(2)-3.91%
Max Revenue beat(2)-0.84%
Revenue beat(4)1
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-3.91%
Max Revenue beat(4)0.84%
Revenue beat(8)1
Avg Revenue beat(8)-3.31%
Revenue beat(12)2
Avg Revenue beat(12)-2.65%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.1%
EPS NY rev (1m)-1.28%
EPS NY rev (3m)-2.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.73
P/FCF N/A
P/OCF 82.99
P/B 8.27
P/tB 9.52
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.4
OCFY1.2%
SpS5.78
BVpS4.01
TBVpS3.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.34%
ROE -19.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.17%
FCFM N/A
ROA(3y)-18.09%
ROA(5y)-25%
ROE(3y)-27.38%
ROE(5y)-34.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.07%
GM growth 5Y-3.64%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.2%
Cap/Sales 11.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.57
Altman-Z 5.1
F-Score6
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)214.02%
Cap/Depr(5y)216.82%
Cap/Sales(3y)21.82%
Cap/Sales(5y)21.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y17.79%
EPS Next 2Y23.55%
EPS Next 3Y18.73%
EPS Next 5Y16.98%
Revenue 1Y (TTM)21.72%
Revenue growth 3Y38.34%
Revenue growth 5Y21.51%
Sales Q2Q%13.04%
Revenue Next Year16.55%
Revenue Next 2Y16.63%
Revenue Next 3Y17.69%
Revenue Next 5Y18.61%
EBIT growth 1Y32.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.76%
EBIT Next 3Y37.12%
EBIT Next 5Y27.62%
FCF growth 1Y77.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y188.17%
OCF growth 3YN/A
OCF growth 5Y-24.51%